10.9. Analysis.
Comparison 10 Efficacy at three years: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD), Outcome 9 No progression of joint damage (TSS ≤ 0.5).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.